QA: Kintara Therapeutics Inc. in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001498382_2021_Kintara_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001498382')"}

Graph

Absolute values for 0001498382, Kintara Therapeutics Inc.

  xvar xval
0 AssetsCurrent 2,851,084
1 IntangibleAssetsNetIncludingGoodwill 2,109
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 84,944
4 LiabilitiesCurrent 0
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 2,674,923
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,514,520
9 ResearchAndDevelopmentExpense 3,630,024
10 remainder_Expenses 1,053,697
11 remainder_Revenues 0
12 remainder_NetIncome 72,325
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 2,938,137
1 Liabilities 2,674,923
2 Expenses 9,198,241
3 Revenues 0
4 StockholdersEquity 263,214
5 NetIncome -9,125,916
6 ComprehensiveNetIncome -9,125,916
7 BaseVar 7,441,813
8 EconomicCapitalRatio -3.09

Edgar->Model Mapping

Feature Distribution

Change over Time